GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PEPTONIC medical AB (XSAT:PMED) » Definitions » EV-to-FCF

PEPTONIC medical AB (XSAT:PMED) EV-to-FCF : -1.44 (As of Jun. 08, 2024)


View and export this data going back to 2014. Start your Free Trial

What is PEPTONIC medical AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PEPTONIC medical AB's Enterprise Value is kr34.05 Mil. PEPTONIC medical AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was kr-23.59 Mil. Therefore, PEPTONIC medical AB's EV-to-FCF for today is -1.44.

The historical rank and industry rank for PEPTONIC medical AB's EV-to-FCF or its related term are showing as below:

XSAT:PMED' s EV-to-FCF Range Over the Past 10 Years
Min: -5.51   Med: -2.52   Max: -1.42
Current: -1.43

During the past 11 years, the highest EV-to-FCF of PEPTONIC medical AB was -1.42. The lowest was -5.51. And the median was -2.52.

XSAT:PMED's EV-to-FCF is ranked worse than
100% of 537 companies
in the Drug Manufacturers industry
Industry Median: 21.99 vs XSAT:PMED: -1.43

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-08), PEPTONIC medical AB's stock price is kr0.0102. PEPTONIC medical AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.031. Therefore, PEPTONIC medical AB's PE Ratio for today is At Loss.


PEPTONIC medical AB EV-to-FCF Historical Data

The historical data trend for PEPTONIC medical AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PEPTONIC medical AB EV-to-FCF Chart

PEPTONIC medical AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.34 -5.80 -2.80 -1.25 -2.32

PEPTONIC medical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.44 -2.74 -3.04 -2.32 -3.45

Competitive Comparison of PEPTONIC medical AB's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, PEPTONIC medical AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PEPTONIC medical AB's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PEPTONIC medical AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where PEPTONIC medical AB's EV-to-FCF falls into.



PEPTONIC medical AB EV-to-FCF Calculation

PEPTONIC medical AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=34.047/-23.589
=-1.44

PEPTONIC medical AB's current Enterprise Value is kr34.05 Mil.
PEPTONIC medical AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-23.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PEPTONIC medical AB  (XSAT:PMED) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

PEPTONIC medical AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0102/-0.031
=At Loss

PEPTONIC medical AB's share price for today is kr0.0102.
PEPTONIC medical AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.031.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


PEPTONIC medical AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of PEPTONIC medical AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


PEPTONIC medical AB (XSAT:PMED) Business Description

Traded in Other Exchanges
Address
Gustavslundsvägen 143, Bromma, SWE, SE-167 51
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.

PEPTONIC medical AB (XSAT:PMED) Headlines

No Headlines